Ad is loading...
JVMAX
Price
$29.71
Change
-$0.23 (-0.77%)
Updated
Nov 15 closing price
LMCQX
Price
$37.27
Change
-$0.31 (-0.82%)
Updated
Nov 15 closing price
Ad is loading...

JVMAX vs LMCQX

Header iconJVMAX vs LMCQX Comparison
Open Charts JVMAX vs LMCQXBanner chart's image
JHancock Disciplined Value Mid Cap A
Price$29.71
Change-$0.23 (-0.77%)
VolumeN/A
CapitalizationN/A
Lord Abbett Mid Cap Stock R2
Price$37.27
Change-$0.31 (-0.82%)
VolumeN/A
CapitalizationN/A
JVMAX vs LMCQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMAX vs. LMCQX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMAX is a Buy and LMCQX is a Buy.

FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 23.8B vs. LMCQX (1.23B). JVMAX pays higher dividends than LMCQX: JVMAX (0.67) vs LMCQX (0.20). JVMAX was incepted earlier than LMCQX: JVMAX (27 years) vs LMCQX (17 years). JVMAX (41.00) and LMCQX (41.00) have comparable annual turnover. LMCQX has a lower initial minimum investment than JVMAX: LMCQX (0) vs JVMAX (1000). LMCQX annual gain was more profitable for investors over the last year : 28.40 vs. JVMAX (21.07). JVMAX return over 5 years is better than : 42.69 vs. LMCQX (34.41).
JVMAXLMCQXJVMAX / LMCQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years17 years-
Gain YTD14.31318.24278%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B1.23B1,938%
Annual Yield % from dividends0.670.20339%
Returns for 1 year21.0728.4074%
Returns for 3 years6.263.22194%
Returns for 5 years42.6934.41124%
Returns for 10 years56.9752.33109%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYMT5.960.04
+0.68%
New York Mortgage Trust
ELMD28.81-0.08
-0.28%
Electromed
ARCC21.51-0.07
-0.32%
Ares Capital Corp
APGE47.25-3.76
-7.36%
Apogee Therapeutics
BCDA1.85-0.17
-8.19%
BioCardia Inc.